3-nitropropionic acid

Known as: 3-NP acid, 3-nitropropanoic acid, beta-nitropropionic acid 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1961-2017
0204019612017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Huntington's disease is a progressive, degenerative disease characterized by abnormal body movements called chorea, and a… (More)
Is this relevant?
2005
2005
Oxidative stress and inflammation are implicated in neurodegenerative diseases including Parkinson's disease (PD) and Huntington… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Data on motor behavioural disorders induced by systemic 3-nitropropionic acid, an irreversible inhibitor of mitochondrial… (More)
Is this relevant?
1998
1998
3-Nitropropionic acid, a potent inhibitor of succinate dehydrogenase which thus compromises cellular energy metabolism, evoked… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Impaired energy metabolism may play an important role in neuronal cell death after brain ischemia and in late-onset… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1996
1996
3-Nitroproprionic acid (3-NP) is a plant mycotoxin which produces selective striatal lesions in both experimental animals and in… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
We showed recently that chronic administration of the mitochondrial inhibitor 3-nitropropionic acid (3NP) in primates produces… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Is this relevant?
1994
1994
We examined the effects of chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid (3-NP) in doses… (More)
Is this relevant?
Highly Cited
1993
Highly Cited
1993
An impairment of energy metabolism may underlie slow excitotoxic neuronal death in neurodegenerative diseases. We therefore… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
1993
Highly Cited
1993
The mechanisms of delayed onset and cell death in Huntington's disease (HD) are unknown. One possibility is that a genetic defect… (More)
Is this relevant?